// App-Quantinova.ai

[AB0362] : B-CELL ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY (BAFF) IN POSTMENOPAUSAL RHEUMATOID ARTHRITIS PATIENTS WITH LOW BONE MASS: A POSSIBLE PROTECTIVE ROLE OF HYDROXYCHLOROQUINE

Researchers

Presenter

  • T. A. Gheita

Principal Investigators

  • S. A. Kenawy

  • H. A. Gheita

Medical Centers

  • Pharmacology Department, Atomic Energy Authorization, Cairo, Egypt

Locations

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Osteoporosis

  • Osteopenia

  • Inflammatory Arthritis

Biomarkers

  • B-cell activating factor

  • Bone gamma-carboxyglutamic acid-containing protein

  • Fibrillin-1

  • Bone Mineral Density

Drug/Treatment

  • Alkaline phosphatase

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved